Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has issued an announcement.
Fuso Pharmaceutical Industries, Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with a notable increase in net sales and profits compared to the previous year. The company achieved a 9.3% increase in net sales and over 100% growth in operating and ordinary profits, indicating strong operational efficiency and market demand. The company also announced an increase in annual dividends per share, reflecting its robust financial health and commitment to shareholder returns.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to innovation and quality in the healthcare sector.
Average Trading Volume: 28,744
Technical Sentiment Signal: Buy
Current Market Cap: Yen20.29B
Learn more about 4538 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue